Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...

SAN DIEGO, February 17, 2026--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the publication of a peer-reviewed study in EP ...

Background. The prognostic significance of a second programmed ventricular stimulation (PVS) at electrophysiology study (EPS), when the first PVS is negative for inducible ventricular tachycardia (VT) ...

Early Intensive GDMT Regimen May Boost Recovery in HFrEF Early and intensive guideline-directed medical therapy shows the recovery of heart function within 3 months among patients newly diagnosed with ...

First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...